Cannabis Science, Inc.
548 Market Street
Suite 16645
San Francisco,
CA 94104
United States - Map
Phone: 888-889-0888
Fax: 866-943-5085
Web Site: http://www.cannabisscience.com
| Cannabis Science, Inc. engages in the research and development, production, and commercialization of phytocannabinoid based pharmaceutical products. Its cannabinoid pharmaceuticals targets various serious needs that include neuro-muscular disorders; neuropathic pain related to spinal cord injuries, as well as conditions, such as AIDS/HIV; chronic pain; respiratory inflammation related to both infections, such as influenza and to autoimmune diseases comprising asthma; cancer, including pain management, and control of cancer in conditions, such as pheochromocytoma; digestive illnesses consisting of gastroesophageal reflux disease, crohns disease, and irritable bowel syndrome; dermatological infections, such as flesh eating disease; and sleep disorders. The company offers its products under various product categories, including non-prescription drugs, nutraceuticals, psychoactive medications, and non-psychoactive medications. Cannabis Science, Inc. is based in San Francisco, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Robert J. Melamede Ph. D.,
Chief Exec. Officer, Pres, Sec. |
N/A
| N/A | Mr. Richard Cowan ,
Chief Financial Officer, Principal Accounting Officer, Treasurer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
